Nonlinear Dynamics Selected to Develop Software for Eli Lilly | GenomeWeb

ANN ARBOR, Mich.--Eli Lilly has launched an 18-month software development program with Nonlinear Dynamics here that is designed to accelerate Lilly's drug discovery process. A team of six Nonlinear research scientists will work with chemoinformatics specialists at Lilly to develop datamining software to help reduce the time and expense required to identify high-potential compounds for further drug development and preclinical evaluation. Pilot testing of Nonlinear's preproduction software is scheduled to begin later this year, according to Lilly.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.